Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration
Status:
Recruiting
Trial end date:
2022-04-27
Target enrollment:
Participant gender:
Summary
The purpose of study JZP110-401 is to evaluate solriamfetol pharmacokinetics (PK) in the
breast milk and plasma of healthy postpartum women following the administration of the drug.
The study also aims to estimate the potential daily solriamfetol dose received by the infant
from the breast milk of the nursing mother. The safety and tolerability of single oral doses
of solriamfetol will also be assessed.